Ibrutinib

Information about the Bruton tyrosine kinase (BTK) inhibitor ibrutinib (Imbruvica), commonly used in hematologic neoplasms.

How useful was this post?

Please, click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Share This Content:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending now

Evaluation of the Peripheral Blood Smear
Educational Resources for Hematology/Oncology Fellows
Hypercoagulability (Thrombophilia) Testing During Acute Thrombosis
Hypercoagulability (Thrombophilia) Testing While on Anticoagulation